Industry news, page-23

EMD looks so far ahead of every other player IMO

Emyria has secured exclusive rights to a library of more than 100 novel MDMA analogues from the University of Western Australia creating a unique drug-discovery pipeline "10 Years Of Research"
https://hotcopper.com.au/posts/55044398/single


When you look through who received funding Sydney Uni received about $3.8mill. Good part is there is already Collaboration between Emyria and Professor Iain McGregor (University of Sydney)



Emyria collaborating with Professor Iain McGregor of the University of Sydney to select and prioritise the lead compounds as well as select suitable models that can help predict the therapeutic potential of the hit compounds identified from in vitro screening.

Professor Iain McGregor has expertise in human and preclinical psychopharmacology and the development of small molecules to modulate social and addictive behaviours. Iain is currently Professor of Psychopharmacology and Academic Director of the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney. Professor McGregor’s research interests also involve characterising the effects of novel psychoactive substances such as synthetic cannabinoids, synthetic cathinones and novel hallucinogens.